Hits from the PDAC in Toronto
The globally active investment company Macquarie particularly liked the silver company MAG Silver and recommends to buy the share. Together with Fresnillo, MAG Silver - https://www.commodity-tv.net/c/search_adv/?v=298901 - is developing the Juanicipio Silver Project in Mexico in the Fresnillo Silver District, famous for its silver wealth. MAG Silver owns 44 percent of the project.
Production is scheduled to start in 2020. The recent discovery of the so-called "Venadas vein" increases the exploration potential enormously. For example, 392 grams of silver and 5.54 grams of gold per ton of rock were found. A mining operation with 4,000 tons of processing per day is planned. The experts at Macquarie see a target price of 23 CanDollars for the MAG Silver share.
Cannabis was certainly a commodity that investors at the PDAC were very interested in. At the mining conference the topic was not dealt with directly. However, the industry attracts enormous amounts of capital, which indirectly competes with mining. Cannabis is a rapidly growing market that offers opportunities for investors to invest in the right companies.
Not only the demand for medical purposes is growing, but also the demand in the private sector due to the increasing legalization. And cannabis is a market worth billions, as can be seen from the Global Cannabis Stock Index. The leading stocks in the industry are represented there and the index has roughly tripled from October 2017 to the present day alone.
RavenQuest BioMed - https://www.commodity-tv.net/c/search_adv/?v=298816 - is a Canadian cannabis company that owns facilities in Alberta and Ontario, which means it grows and researches cannabis. Through a recent arrangement with Dutch Passion, RavenQuest BioMed is able to serve self-breeders and commercial micro-breeders with over 60 premium cannabis seeds under its own name and thus further increase its presence in the cannabis market.
Current corporate information and press releases from MAG Silver (https://www.resource-capital.ch/en/companies/mag-silver-corp.html) and RavenQuest BioMed (https://www.resource-capital.ch/en/companies/ravenquest-biomed-inc.html).
In accordance with §34 WpHG, I would like to point out that partners, authors and employees can hold shares in the companies mentioned in each case and therefore there is a possible conflict of interest. Only the English version of these messages applies.
Disclaimer: The information provided does not constitute any form of recommendation or advice. We expressly point out the risks involved in securities trading. No liability can be assumed for damages resulting from the use of this blog. I would like to point out that shares and in particular warrant investments are generally associated with risk. The total loss of the invested capital cannot be excluded. All information and sources are carefully researched. However, no guarantee is given for the correctness of all contents. I expressly reserve the right to make a mistake, in particular with regard to figures and exchange rates, despite the utmost care. The information contained herein has been obtained from sources believed to be reliable but does not claim to be accurate or complete. Due to court rulings the contents of linked external sites are also to answer for (so among other things district court Hamburg, in the judgement of 12.05.1998 - 312 O 85/98), as long as no explicit dissociation from these takes place. Despite careful control of the contents, I do not assume any liability for the contents of linked external sites. The respective operators are solely responsible for their content. The disclaimer of Swiss Resource Capital AG also applies: https://www.resource-capital.ch/en/disclaimer.html